AUG 14, 2019 1:52 PM PDT

Promising Drug Encourages Survival in Pancreatic Cancer

WRITTEN BY: Nouran Amin

Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results in a new report by the University of Michigan Rogel Cancer Center. The study was focused on developing therapeutic treatments for pancreatic cancer patients that are on stages far too advanced for surgical interventions. The drug, AZD1775, was designed to work on inhibiting the effects of an enzyme known as ‘Wee1’ for it role in DNA damage repair in cancer cells.

Learn more on Pancreatic Cancer:

"If we can disable the DNA damage response in pancreatic cancer cells, it might eliminate treatment resistance and sensitize the cancer to the effects of both radiation and chemotherapy," says lead study author Kyle Cuneo, M.D., associate professor of radiation oncology at Michigan Medicine.

Current standard treatments drugs involve gemcitabine along with radiotherapy that damage the DNA of cancer cells. However, these treatments are overcome by the cancer as it has its one way of repairing the damage caused by treatments. The limit of effectiveness of these standard treatments has prompted researchers to develop AZD1775—which is unique in leaving normal cells unaffected while shielding the protection away from pancreatic cancer against the effects of radiotherapy and gemcitabine.

"If we're ever going to cure pancreatic cancer, we're going to need effective systemic treatment as well as local therapy. Our data suggests that AZD1775 can do both," says senior study author Ted Lawrence, M.D., Ph.D., Isadore Lampe Professor and chair of radiation oncology at Michigan Medicine.

"Adding AZD1775 to radiation and gemcitabine was relatively well tolerated with encouraging survival results. Further studies with this promising combination are needed," Cuneo says.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 01, 2020
Immunology
Scar-Free Healing Starts With Mobilizing the Immune System
DEC 01, 2020
Scar-Free Healing Starts With Mobilizing the Immune System
Thanks to a new hydrogel biomaterial developed by researchers at Duke University, we are one step closer to the holy gra ...
DEC 27, 2020
Drug Discovery & Development
Attacking Mitochondria in Tumors
DEC 27, 2020
Attacking Mitochondria in Tumors
Researchers found that attacking a cell’s mitochondria can starve cancer cells. The study involves a possible ther ...
DEC 29, 2020
Cannabis Sciences
What Happens When You Combine Cannabis with Psychedelics?
DEC 29, 2020
What Happens When You Combine Cannabis with Psychedelics?
Despite the growing popularity of cannabis and psychedelics, there is a shortage of research on how the two interact. Be ...
JAN 01, 2021
Microbiology
A New Type of Antibiotics Help the Immune System Fight Pathogens
JAN 01, 2021
A New Type of Antibiotics Help the Immune System Fight Pathogens
Reporting in Nature, scientists have identified a new group of compounds that may help us get out of the antibiotic-resi ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
FEB 10, 2021
Drug Discovery & Development
Black Men Respond Best to Immunotherapy for Prostate Cancer
FEB 10, 2021
Black Men Respond Best to Immunotherapy for Prostate Cancer
Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men f ...
Loading Comments...